Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [41] Venlafaxine in children and adolescents with attention deficit hyperactivity disorder
    Mukaddes, NM
    Abali, O
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (01) : 92 - 95
  • [42] Treatment of attention deficit hyperactivity disorder in children
    Kehoe, WA
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1130 - 1134
  • [43] Treatment of attention deficit hyperactivity disorder in children
    van der Oord, Saskia
    Prins, P. J. M.
    Oosterlaan, J.
    Emmelkamp, P. M. G.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2008, 17 (02) : 73 - 81
  • [44] Methylphenidate in the treatment of children and adolescents with bipolar disorder and Attention-Deficit/Hyperactivity disorder
    Findling, Robert L.
    Short, Elizabeth J.
    McNamara, Nora K.
    Demeter, Christine A.
    Stansbrey, Robert J.
    Gracious, Barbara L.
    Whipkey, Resaca
    Manos, Michael J.
    Calabrese, Joseph R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (11): : 1445 - 1453
  • [45] Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Spencer, Thomas J.
    Greenbaum, Michael
    Ginsberg, Lawrence D.
    Murphy, William Rory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 501 - 510
  • [46] The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder
    Meyers, Juliana
    Gajria, Kavita
    Candrilli, Sean D.
    Fridman, Moshe
    Sikirica, Vanja
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 109 - 125
  • [47] Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
    Sallee, Floyd R.
    McGgough, James
    Wigal, Tim
    Donahue, Jessica
    Lyne, Andrew
    Biederman, Joseph
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (02): : 155 - 165
  • [48] Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Cutler, Andrew J.
    Brams, Matthew
    Bukstein, Oscar
    Mattingly, Gregory
    McBurnett, Keith
    White, Carla
    Rubin, Jonathan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (10): : 1092 - 1101
  • [49] Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
    Huss, Michael
    McBurnett, Keith
    Cutler, Andrew J.
    Hervas, Amaia
    Bliss, Caleb
    Gao, Joseph
    Dirks, Bryan
    Newcorn, Jeffrey H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (03) : 432 - 443
  • [50] Determination of Guanfacine in Oral Fluid and Serum of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Short Communication
    Wohkittel, Christopher
    Scherf-Clavel, Oliver
    Fekete, Stefanie
    Romanos, Marcel
    Hoegger, Petra
    Gerlach, Manfred
    THERAPEUTIC DRUG MONITORING, 2022, 44 (02) : 340 - 344
12345